Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis

Journal of Medical Virology

Volumn 84, Issue 7, 2012, Pages 1084-1088

  Faber, Tina E ^a   Groen, Henk ^b   Welfing, Martine ^a   Jansen, Koos J G ^c   Bont, Louis J ^c  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokines and chemokines; Innate immune responses; Interleukin 17; Respiratory syncytial virus

Indexed keywords

EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 6;

ADAPTIVE IMMUNITY; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CLINICAL ARTICLE; CONVALESCENCE; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFANT; INFANT DISEASE; INNATE IMMUNITY; MALE; NASOPHARYNGEAL ASPIRATION; PATHOGENESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

BRONCHIOLITIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-17; MALE; NASOPHARYNX; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84860997738     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23291     Document Type: Article

References (24)

1. Aggarwal S, Gurney AL. 2002. IL-17: Prototype member of an emerging cytokine family. J Leukoc Biol 71: 1-8.
2. Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, van den Ende K, Kimpen JL, Strengers JL, Bont LJ. 2007. Down syndrome: A novel risk factor for respiratory syncytial virus bronchiolitis-A prospective birth-cohort study. Pediatrics 120: 1076-1081.
3. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RA, Kimpen JL. 2001. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 184: 355-358.
4. Cua DJ, Tato CM. 2010. Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 10: 479-489.
5. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. 2003. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10: 133-139.
6. DeVincenzo JP, El Saleeby CM, Bush AJ. 2005. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 191: 1861-1868.
7. Garafalo RJ, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. 2001. Macrophage inflammatory protein 1α (not T-helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 184: 393-399.
8. Houben ML, Coenjaerts FE, Rossen JW, Belderbos ME, Hofland RW, Kimpen JL, Bont L. 2010. Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol 82: 1266-1271.
9. Joshi P, Kakakios A, Jayasekera J, Isaacs D. 1998. A comparison of IL-2 levels in nasopharyngeal and endotracheal aspirates of babies with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 102: 618-620.
10. Kawaguchi M, Fujita J, Kokubu F, Huang SK, Homma T, Matsukura S, Adachi M, Hizawa N. 2009. IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway. Am J Physiol Lung Cell Mol Physiol 296: 804-810.
11. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
12. Larrañaga CL, Ampuero SL, Luchsinger VF, Carrión FA, Aguilar NV, Morales PR, Palomino MA, Tapia LF, Avendaño LF. 2009. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 28: 867-873.
13. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, Tighe M, Hamada H, Sell S, Dutton RW, Swain SL. 2009. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353-7363.
14. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. 2003. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child. 88: 922-926.
15. McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL. 2004. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 23: 106-112.
16. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW. 2011. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 179: 248-258.
17. Onishi RM, Gaffen SL. 2010. Interleukin-17 and its target genes: Mechanisms of interleukin-17 function in disease. Immunol 129: 311-321.
18. Resch B, Manzoni P, Lanari M. 2009. Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes. Paediatr Respir Rev 10: 148-153.
19. Schuurhof A, Janssen R, de Groot H, Hodemaekers HM, de Klerk A, Kimpen JL, Bont L. 2011. Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze. Respir Res 12: 121-123.
20. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sánchez PJ, Ramilo O. 1999. Elevated cytokine concentrations in the nasal pharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis 18: 115-122.
21. Smyth RL, Mobbs KJ, O'Hea U, Ashby D, Hart CA. 2002. Respiratory syncytial virus bronchiolitis: Disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol 33: 339-346.
22. Welliver RC. 2003. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 143: 112-117.
23. Welliver RC, Garofalo RP, Ogra PL. 2002. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J 21: 457-461.
24. Xie D, Hai B, Xie X, Liu L, Ayello J, Ma X, Zhang J. 2009. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines. Cell Immunol 259: 157-164.